Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2018 ASCO Annual Meeting /
New pathways in pancreatic cancer

1st - 5th Jun 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.06.18
Views: 438

Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA

Dr Sanchez speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about new pathways to standardise care in pancreatic cancer. He highlights the need to first asses the effectiveness of the treatment and then evaluate the treatment with the least toxicity for the patient before determining the cost to the institution.

He goes on to discuss the need to standardise pathways in order to improve the standard of care for patients.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation